Sat, Sep 20, 2014, 10:59 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • clarefrancis85721 clarefrancis85721 Mar 29, 2013 11:06 PM Flag

    arikace will serve a small patient base//THAT IS WHY IT IS ORPHAN!

    spelling aside,this is a correct statement..No one knows how Arikace will be used in therapy.===yet.===== or how effective so by orphaning Arikace gives Insmed advantage.This is a board for stock holders who think you can rank out reality.I wish you all a Happy Easter and best success for Arikace.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Hiding behind skirts now, are we Terry? You know , of course, that this new orphan designation is for NTM alone. 50,000 cases of NTM lung disease were treated by physicians in the U.S. during 2011. There is no current FDA-approved treatment for NTM lung infection. So, according to you, no one has any clue how Arikace will be used in therapy. I predict that it will not be used to cure spina bifida, male erectile dysfunction or whatever affliction you suffer from, which appears incurable, judging by your perpetually jejune ejaculations.

 
INSM
13.21+0.03(+0.23%)Sep 19 4:15 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.